Literature DB >> 24900176

Exploring target-selectivity patterns of molecular scaffolds.

Ye Hu1, Jürgen Bajorath1.   

Abstract

We investigate the question of whether target-selective molecular scaffolds can be identified on the basis of currently available compound activity data. Starting from a pool of 17745 public domain compounds with activity annotations for 433 human targets, we ultimately identify, through a selectivity classification and database-mining approach, 42 molecular scaffolds represented by multiple compounds that are highly selective for a particular target over one or more others. In many other cases, individual compounds representing unique scaffolds are target-selective. Hence, currently available public domain compound selectivity data are sparse. However, we also identify selectivity patterns that evolve around specific targets and are formed by multiple target-selective scaffolds. These scaffolds should provide interesting starting points for further chemical exploration.

Entities:  

Keywords:  Molecular selectivity; compound database mining; privileged substructures; selectivity patterns; target family selective molecular scaffolds; target-selective scaffolds

Year:  2010        PMID: 24900176      PMCID: PMC4007699          DOI: 10.1021/ml900024v

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  7 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  Are target-family-privileged substructures truly privileged?

Authors:  Dora M Schnur; Mark A Hermsmeier; Andrew J Tebben
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

3.  Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families.

Authors:  Ye Hu; Anne Mai Wassermann; Eugen Lounkine; Jürgen Bajorath
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

4.  Data completeness--the Achilles heel of drug-target networks.

Authors:  Jordi Mestres; Elisabet Gregori-Puigjané; Sergi Valverde; Ricard V Solé
Journal:  Nat Biotechnol       Date:  2008-09       Impact factor: 54.908

5.  The properties of known drugs. 1. Molecular frameworks.

Authors:  G W Bemis; M A Murcko
Journal:  J Med Chem       Date:  1996-07-19       Impact factor: 7.446

6.  Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.

Authors:  B E Evans; K E Rittle; M G Bock; R M DiPardo; R M Freidinger; W L Whitter; G F Lundell; D F Veber; P S Anderson; R S Chang
Journal:  J Med Chem       Date:  1988-12       Impact factor: 7.446

7.  BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities.

Authors:  Tiqing Liu; Yuhmei Lin; Xin Wen; Robert N Jorissen; Michael K Gilson
Journal:  Nucleic Acids Res       Date:  2006-12-01       Impact factor: 16.971

  7 in total
  2 in total

1.  Freely available compound data sets and software tools for chemoinformatics and computational medicinal chemistry applications.

Authors:  Ye Hu; Jurgen Bajorath
Journal:  F1000Res       Date:  2012-08-14

2.  Follow up: Compound data sets and software tools for chemoinformatics and medicinal chemistry applications: update and data transfer.

Authors:  Ye Hu; Jürgen Bajorath
Journal:  F1000Res       Date:  2014-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.